Tuning In With Radiobotics

If you’re in the Danish Healthtech ecosystem, you’ve likely heard about Radiobotics, a startup making strides in AI-driven radiological analysis. They won TechBBQ’s Life Science Pitch Competition, and went on to win the 2020 MEDICA Startup Competition in Germany. In a period where many companies have seen great difficulty, Radiobotics has grown tremendously with no signs of slowing down.

This week, we sat down (virtually) with Stine Mølgaard Sørensen, co-founder and COO of Radiobotics to talk about how they’ve grown, dealt with COVID-19 and other uncertainties, and put themselves on the path to global market penetration.

Winning the TechBBQ Life Science Pitch Competition was a part of Radiobotics’ effort to increase their ecosystem profile and raise awareness of the work they’re doing. In the midst of the ongoing COVID-19 pandemic, getting attention from winning these two competitions was “the kind of attention you need,” according to Stine.

Being a healthtech startup, Radiobotics works directly with hospitals, which has understandably been difficult over the past year. They’ve learned to strike a balance with continuing their commercial growth while maintaining a good relationship with healthcare providers. However, hospitals still have a lot to consider when assessing new AI solutions— depending on the hospital, Stine says, there's still a lot of hard work ahead to ensure the highest impact both from a clinical and financial perspective.

This is where their results can speak for themselves. Besides winning the two competitions mentioned above, Radiobotics has received CE-approval from the EU for use in healthcare, and is currently awaiting approval from the United States Food and Drug Administration. According to Stine, validation from the ecosystem and national institutions go a long way towards Radiobotics proving their value, safety, and efficacy to potential clients.